跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,118 条关于
“TREM2+ LAM”
全部
2,118
临床试验
1,399
药物
304
机构
146
资讯
269
3个月前
CUHK Researchers Uncover TREM2+ LAM Macrophage Mechanism Driving Liver Cancer Immunotherapy Resistance
去年
TREM2 Emerges as Dual Regulator of Lipid Metabolism and Immune Response in MASH
去年
Vigil Neuroscience Advances Dual TREM2 Programs with Promising Results for Neurodegenerative Diseases
去年
Vigil Neuroscience's VG-3927 Shows Promise in Phase 1 Alzheimer's Trial, Advancing to Phase 2
4个月前
Quince Therapeutics Reports Positive Phase 2a Results for LAM-001 in Pulmonary Hypertension
10个月前
Muna Therapeutics Initiates Phase 1 Trial of Novel Oral TREM2 Agonist MNA-001 for Early Alzheimer's Disease
9个月前
Two Novel Alzheimer's Therapies Advance in Phase 2 Trials: Oral PRI-002 and TREM2-Targeting VHB937
去年
Sanofi to Acquire Vigil Neuroscience for Up to $600 Million, Expanding Alzheimer's Disease Pipeline
上个月
Hetao Zone Poised to Accelerate Hong Kong's Medical R&D Ambitions Through Cross-Border Clinical Trials
3个月前
Calibrating Microglia States in Alzheimer's Disease: From Anti-Amyloid Antibodies to Multi-Target Microenvironment Protection
第 1 页,共 27 页
上一页
下一页